Trials / NCT00279500
Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa
Completed N/A Retinal implant, Electrical stimulation
- Sponsor
- Second Sight Medical Products
- Treatment
- Argus 16 Retinal Stimulation System
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to no upper limit
- Enrollment
- 6 participants
- Started
- 2002-02-27
- Main results expected
- 2014-12-31
- Results posted
- Yes
- Record last updated
- 2023-04-12
What the study is testing
The objective of this study is to evaluate the safety and efficacy of the retinal stimulation system by evaluating the data after chronic implantation.
Where it runs
United States (1)
- Doheny Eye Institute, Los Angeles, California